Embecta Corp. (EMBC)
5.16
-0.39
(-7.03%)
USD |
NASDAQ |
Sep 09, 13:58
Embecta Shareholders Equity (Quarterly) : -612.70M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -612.70M |
| March 31, 2026 | -626.10M |
| December 31, 2025 | -613.10M |
| September 30, 2025 | -650.60M |
| June 30, 2025 | -669.60M |
| March 31, 2025 | -736.20M |
| December 31, 2024 | -768.80M |
| September 30, 2024 | -738.30M |
| June 30, 2024 | -763.70M |
| March 31, 2024 | -769.60M |
| Date | Value |
|---|---|
| December 31, 2023 | -793.50M |
| September 30, 2023 | -821.70M |
| June 30, 2023 | -809.40M |
| March 31, 2023 | -822.60M |
| December 31, 2022 | -836.10M |
| September 30, 2022 | -891.40M |
| June 30, 2022 | -847.60M |
| March 31, 2022 | -967.50M |
| December 31, 2021 | 550.50M |
| September 30, 2021 | 594.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Artivion, Inc. | 445.58M |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.265B |
| Total Liabilities (Quarterly) | 1.878B |
| Debt to Equity Ratio | -2.451 |
| Current Ratio | 1.680 |
| Net Debt Paydown Yield | 7.24% |